| Mepha Pharma AG - Apremilast-Mepha 30 mg, Filmtabletten | | 69498 | | 03 | | Apremilast-Mepha 30 mg | | Filmtabletten | | L04AA32 | | Apremilast | | 22.07.2025 | | |
| | Composition | | apremilastum 30 mg, lactosum monohydricum 120 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.81 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 3350, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Apremilastum | 30 mg |
| | BAG: Active Agent | Dose |
|---|
| Apremilastum | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 120 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 56 | 292.31 | 334.85 | B | SL | No |
|
|
